Literature DB >> 4136153

Common antigenic structures of HL-A antigens. II. Small fragments derived from papain-solubilized HL-A antigen molecules.

N Tanigaki, M Katagiri, K Nakamuro, V P Kreiter, D Pressman.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4136153      PMCID: PMC1423124     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  8 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Characterization of soluble substances in plasma carrying HL-A alloantigenic activity and HL-A common antigenic activity.

Authors:  Y Miyakawa; N Tanigaki; V P Kreiter; G E Moore; D Pressman
Journal:  Transplantation       Date:  1973-03       Impact factor: 4.939

3.  Determination of HL-A zygosity by radioimmunoassay.

Authors:  Y Miyakawa; N Tanigaki; V P Kreiter; G E Moore; D Pressman
Journal:  Transplantation       Date:  1972-12       Impact factor: 4.939

4.  Ultracentrifuge studies on the effects of thiocyanate ion on antigen--antibody systems.

Authors:  V A De Saussure; W B Dandliker
Journal:  Immunochemistry       Date:  1969-01

5.  Papain-solubilized HL-A antigens from cultured human lymphocytes contain two peptide fragments.

Authors:  P Cresswell; M J Turner; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

6.  Human transplantation antigens: isolation and radioimmunoassay.

Authors:  Y Miyakawa; N Tanigaki; Y Yagi; D Pressman
Journal:  Proc Soc Exp Biol Med       Date:  1971-03

7.  HL-A antigens from hematopoietic cell lines: molecular size and electrophoretic mobility.

Authors:  N Tanigaki; Y Miyakawa; Y Yagi; D Pressman
Journal:  J Immunol       Date:  1971-08       Impact factor: 5.422

8.  An efficient method for isolation of HL-A antigens from hematopoietic cell lines.

Authors:  Y Miyakawa; N Tanigaki; Y Yagi; D Pressman
Journal:  J Immunol       Date:  1971-08       Impact factor: 5.422

  8 in total
  7 in total

1.  Evolutionary relationship between immunoglobulins and transplantation antigens.

Authors:  P A Peterson; L Rask; K Sege; L Klareskog; H Anundi; L Ostberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  Immunological and chemical purity of papain-solubilized HL-A antigens.

Authors:  P Parham; C Terhorst; H Herrmann; R E Humphreys; M D Waterfield; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

3.  Common antigenic structures of HL-A antigens. 3. An HL-A common antigenic marker closely associated with HL-A alloantigenic activity and detected by use of rabbit anti-rhesus monkey cell membrane antibodies.

Authors:  M Katagiri; N Tanigaki; V P Kreiter; D Pressman
Journal:  Immunology       Date:  1974-09       Impact factor: 7.397

4.  Common antigenic structures of HL-A antigens. IV. HL-A common portion fragment isolated from spent culture medium of human lymphoid cell lines.

Authors:  K Nakamuro; N Tanigaki; V P Kreiter; D Pressman
Journal:  Immunology       Date:  1974-12       Impact factor: 7.397

5.  HLA class I binding of synthetic nonamer peptides carrying major anchor residue motifs of HLA-B27 (B*2705)-binding peptides.

Authors:  D Fruci; P Rovero; R H Butler; R Sorrentino; R Tosi; N Tanigaki
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

6.  Plasma-membrane-associated immunoglobulins and other polypeptides of pig mesenteric node lymphocytes.

Authors:  S I Chavin; S M Johnson; A Holliman
Journal:  Biochem J       Date:  1975-06       Impact factor: 3.857

7.  Common antigenic structures of HL-A antigens. VI. Common antigenic determinants located on the 33,000 Dalton alloantigenic fragment portion of papain-solubilized HL-A molecules.

Authors:  K Nakamuro; N Tanigaki
Journal:  Immunology       Date:  1975-12       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.